These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9192821)

  • 1. Alteration in gamma-glutamyl transpeptidase activity and messenger RNA of human prostate carcinoma cells by androgen.
    Ripple MO; Pickhardt PA; Wilding G
    Cancer Res; 1997 Jun; 57(12):2428-33. PubMed ID: 9192821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
    Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
    J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
    Ripple MO; Henry WF; Rago RP; Wilding G
    J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of glyceraldehyde-3-phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cells.
    Ripple MO; Wilding G
    Cancer Res; 1995 Oct; 55(19):4234-6. PubMed ID: 7671226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
    Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver.
    Obrador E; Carretero J; Ortega A; Medina I; Rodilla V; Pellicer JA; Estrela JM
    Hepatology; 2002 Jan; 35(1):74-81. PubMed ID: 11786961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic effect of androgens on prostate cancer cells and its correlation with androgen receptor coactivator dopa decarboxylase.
    Shao C; Wang Y; Yue HH; Zhang YT; Shi CH; Liu F; Bao TY; Yang ZY; Yuan JL; Shao GX
    J Androl; 2007; 28(6):804-12. PubMed ID: 17581945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F activity is biphasically regulated by androgens in LNCaP cells.
    Hofman K; Swinnen JV; Verhoeven G; Heyns W
    Biochem Biophys Res Commun; 2001 Apr; 283(1):97-101. PubMed ID: 11322773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
    Lin MF; DaVolio J; Garcia-Arenas R
    Cancer Res; 1992 Sep; 52(17):4600-7. PubMed ID: 1380886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G
    Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
    Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gamma-Glutamyl transpeptidase in normal and neoplastic prostate glands.
    Frierson HF; Theodorescu D; Mills SE; Hanigan MH
    Mod Pathol; 1997 Jan; 10(1):1-6. PubMed ID: 9021720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D; Shaw K; Jazayeri J; Leedman PJ
    Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.
    el-akawi Z; Zdanowicz J; Creaven PJ; Abu-hadid M; Perez R; Pendyala L
    Oncol Res; 1996; 8(10-11):415-23. PubMed ID: 9114434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
    Gleave M; Tolcher A; Miyake H; Nelson C; Brown B; Beraldi E; Goldie J
    Clin Cancer Res; 1999 Oct; 5(10):2891-8. PubMed ID: 10537358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia increases androgen receptor activity in prostate cancer cells.
    Park SY; Kim YJ; Gao AC; Mohler JL; Onate SA; Hidalgo AA; Ip C; Park EM; Yoon SY; Park YM
    Cancer Res; 2006 May; 66(10):5121-9. PubMed ID: 16707435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.